# US 2025/0085281 A1 · Detecting antibodies using antigens

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0085281 A1
- Document ID: US20250085281A1
- Status: Published application
- Kind: A1
- Application number: 18/825,426
- Filed: 2024-09-05
- Published: 2025-03-13
- Earliest claimed: 2023-09-12
- Assignees: Inova Diagnostics, Inc.
- Applicants: Inova Diagnostics, Inc.
- Inventors: Michael Mahler; Chelsea Bentow
- Web page: https://patentgrep.com/patent/US20250085281A1

## CPC

- G01N 33/54353: {with ligand attached to the carrier via a chemical coupling agent (coatings G01N33/54393)}
- G01N 33/564: for pre-existing immune complex or autoimmune disease {, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9}
- G01N 33/54313: {the carrier being characterised by its particulate form}
- G01N 33/54386: {Analytical elements}
- G01N 2800/10: Musculoskeletal or connective tissue disorders
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

An example complex includes a solid support and at least two different types of antigens attached to the solid support. The complex includes a carrier protein attached to the solid support. At least one of the different types of antigens is attached to the carrier protein. The at least one of the different types of antigens is attached to the solid support through the carrier protein.

## Claims

### Claim 1

A complex comprising:
a solid support; and
at least two different types of antigens attached to the solid support.

### Claim 2 (depends on 1)

The complex of claim 1, further comprising:
a carrier attached to the solid support;
wherein at least one of the different types of antigens is attached to the carrier, the at least one of the different types of antigens being attached to the solid support through the carrier.

### Claim 3 (depends on 2)

The complex of claim 2, further comprising:
a linker to attach the at least one of the different types of antigens to the carrier.

### Claim 4 (depends on 3)

The complex of claim 3, wherein the linker comprises a polyethylene glycol (PEG) spacer or biotin.

### Claim 5 (depends on 2)

The complex of claim 2, wherein the carrier comprises at least one of streptavidin, a polymerized protein, polymerized streptavidin with biotin, bovine serum albumin (BSA), human serum albumin (HSA), polyethylene glycol (PEG) spacer attachment, or adipic acid dihydrazide (ADH).

### Claim 6 (depends on 1)

The complex of claim 1, further comprising:
multiple carriers, each of the carriers being attached to the solid support;
wherein each of the different types of antigens is attached to a respective one of the multiple carriers, each of the different types of antigens being attached to the solid support through the respective one of the multiple carriers.

### Claim 7 (depends on 1)

The complex of claim 1, further comprising:
a carrier attached to the solid support;
wherein each of the different types of antigens is attached to the carrier, each of the different types of antigens being attached to the solid support through the carrier.

### Claim 8 (depends on 1)

The complex of claim 1, wherein the at least two different types of antigens comprise a group of markers for a disease or condition of a subject

### Claim 9 (depends on 1)

The complex of claim 1, wherein at least one of the different types of antigens is part of a cellular extract that is attached to the solid support.

### Claim 10 (depends on 1)

The complex of claim 1, wherein a first one of the different types of antigens comprises a purified antigen and a second one of the different types of antigens is part of a cellular extract.

### Claim 11 (depends on 1)

The complex of claim 1, wherein the at least two different types of antigens comprise at least two of the following: Scl-70, centromere, dsDNA, Ro52, Ro60, SS-B, Ribo-P, DFS-70, EJ, Sp100, Gp210, actin, AMA-M2, AMA-M2/MIT3, TIF1-γ, NXP-2, SAE, PL-7, PL-12, OJ, HMGCR, SRP, Mi-2, MDA-5, RNA Helicase, Ki/SL, Sm/RNP, SS-A, PM/Scl, RNA Pol III, Th/To, Fibrillarin, Sm, Ku, Jo-1, RNP, BICD2, HK, KL, LC1, LKM-1, SLA, SS-A/Ro52, Scl-70, Ku, Centromere proteins, U11/U12 RNP, Hexokinase-1, or Kelch-12.

### Claim 12 (depends on 1)

The complex of claim 1, where at least one of the different types of antigens binds to an antinuclear antibody (ANA).

### Claim 13 (depends on 1)

The complex of claim 1, further comprising:
a label associated with the solid support, the label being associated with a disease, condition, or analyte that is detectable using the at least two different antigens.

### Claim 14

A kit comprising:
a first solid support comprising first antigens attached thereto, the first antigens comprising at least two different types of antigens; and
a second solid support comprising at least one second antigen attached thereto, the at least one second antigen being different than each of the first antigens;
wherein one or more of the first antigens or the at least one second antigens comprises a purified antigen or is part of a cellular extract.

### Claim 15 (depends on 14)

The kit of claim 14, wherein the first solid support comprises a first label and the second solid support comprises a second label, the first label being different from the second label.

### Claim 16 (depends on 14)

The kit of claim 14, wherein the first antigens comprise markers for a first disease or condition, the first label being associated with the first disease or condition; and
wherein the at least one second antigen comprises a marker for a second disease or condition, the second label being associated with the second disease or condition.

### Claim 17 (depends on 14)

The kit of claim 14, wherein the first antigens comprise first labels that produce a signal in response to binding with corresponding antibodies; and
wherein the at least one second antigen comprises at least one second label that produces a signal in response to binding with at least one corresponding antibody;
wherein the first labels and the at least one second label are of a same type or of a different type.

### Claim 18

A method comprising:
contacting a biological sample from a subject with a complex comprising:
a solid support; and
at least two different types of antigens attached to the solid support; and
detecting a presence of an antibody in the biological sample bound to the complex, where the presence of the antibody bound to the complex is indicative of a disease.

### Claim 19 (depends on 18)

The method of claim 18, further comprising:
detecting the solid support based on a label on the solid support, the label being associated the disease;
wherein detecting comprises detecting signals from labels on the at least two different types of antigens.

### Claim 20 (depends on 18)

The method of claim 18, wherein the complex is one of multiple complexes that contacts the biological sample, each of the multiple complexes having a different configuration associated with a different disease, each of the multiple complexes comprising:
a respective solid support; and
one or more antigens attached to the respective solid support.
